Business
Natco Pharma Limited Press Release Mar 03 2026
Natco Pharma Limited has informed the Exchange regarding a press release dated March 03, 2026, titled "NATCO announces launch of Pomalidomide Capsules (generic of Pomalyst®) in the U.S. market".
About this update from Natco Pharma Limited
Natco Pharma Limited has informed the Exchange regarding a press release dated March 03, 2026, titled "NATCO announces launch of Pomalidomide Capsules (generic of Pomalyst®) in the U.S. market". View Attachment
View stock analysis, news, and events for Natco Pharma Limited